Prime Movers Lab Fund I LP - Sep 6, 2022 Form 4 Insider Report for Vaxxinity, Inc. (VAXX)

Role
10%+ Owner
Signature
Prime Movers Lab Fund I LP /s/ Taylor Frankel, Authorized Person
Stock symbol
VAXX
Transactions as of
Sep 6, 2022
Transactions value $
-$89,768
Form type
4
Date filed
9/8/2022, 04:55 PM
Previous filing
Aug 25, 2022
Next filing
Dec 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VAXX Class A Common Stock Sale -$14.3K -5.95K -0.27% $2.40 2.23M Sep 6, 2022 Held by COVAXX PML SPV 1 LP F1, F6, F7
transaction VAXX Class A Common Stock Sale -$5.37K -2.23K -0.27% $2.40 836K Sep 6, 2022 Held by COVAXX PML SPV 2 LP F2, F6, F7
transaction VAXX Class A Common Stock Sale -$9.45K -3.93K -0.27% $2.40 1.47M Sep 6, 2022 Held by COVAXX PML SPV 3 LP F3, F6, F7
transaction VAXX Class A Common Stock Sale -$60.7K -25.2K -0.27% $2.40 9.45M Sep 6, 2022 Direct F5, F6, F7
holding VAXX Class A Common Stock 3.62M Sep 6, 2022 Held by Prime Movers Growth Fund 1 LP F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1.
F2 Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2.
F3 Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3.
F4 Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG.
F5 Held by PML. PML GP I is the general partner of PML.
F6 Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein.
F7 The price of $2.4029 per share represents a weighted average of purchase prices ranging from $2.40 to $2.42 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.